BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

345 related articles for article (PubMed ID: 11662883)

  • 1. Business and the academy.
    Bok DC
    Harv Mag; 1981; 83(5):23-35. PubMed ID: 11662883
    [No Abstract]   [Full Text] [Related]  

  • 2. Conflicts of interest.
    Nature; 1989 Aug; 340(6236):664. PubMed ID: 11644385
    [No Abstract]   [Full Text] [Related]  

  • 3. Public-private partnerships in biomedical research: resolving conflicts arising under the Federal Technology Transfer Act of 1986.
    Bulleit TN
    J Law Health; 1989-1990; 4(1):1-20. PubMed ID: 11652568
    [No Abstract]   [Full Text] [Related]  

  • 4. University physician-researcher conflicts of interest: the inadequacy of current controls and proposed reform.
    Maatz CT
    High Technol Law J; 1992; 7():137-88. PubMed ID: 11659962
    [No Abstract]   [Full Text] [Related]  

  • 5. Pitching doctors.
    Wilkes MS; Shuchman M
    N Y Times Mag; 1989 Nov; ():88, 90, 126, 128-129. PubMed ID: 11650264
    [No Abstract]   [Full Text] [Related]  

  • 6. FDA issues concerning conflicts of interest.
    Kurt TL
    IRB; 1990; 12(5):6-9. PubMed ID: 11654003
    [No Abstract]   [Full Text] [Related]  

  • 7. Risky alliance on medicine's cutting edge: firm faces business, ethics issues in NIH joint venture.
    Lehrman S
    Washington Post; 1991 Aug; ():Business 1, 14. PubMed ID: 11646923
    [No Abstract]   [Full Text] [Related]  

  • 8. Report urges freedom for genetic engineers.
    New Sci; 1981 Apr; 90(1247):8. PubMed ID: 11664138
    [No Abstract]   [Full Text] [Related]  

  • 9. Federal agency revises rule on financial disclosure by researchers.
    Maloney DM
    Hum Res Rep; 1999 Feb; 14(2):1-2. PubMed ID: 11657602
    [No Abstract]   [Full Text] [Related]  

  • 10. Pushing drugs to doctors.
    Consum Rep; 1992 Feb; 57(2):87-94. PubMed ID: 11651202
    [No Abstract]   [Full Text] [Related]  

  • 11. Teaching scientific integrity.
    Gifford F
    Centen Rev; 1994; 38(2):297-314. PubMed ID: 11656760
    [No Abstract]   [Full Text] [Related]  

  • 12. The brave new world of biomedical research.
    Coste C
    New Physician; 1977 Jul; 26(7):18-22. PubMed ID: 11663036
    [No Abstract]   [Full Text] [Related]  

  • 13. Winning through intimidation?
    Budiansky S
    US News World Rep; 1987 Aug; 103(9):48-9. PubMed ID: 11653798
    [No Abstract]   [Full Text] [Related]  

  • 14. Patenting of life forms.
    Pautler G
    Trial; 1982 Apr; 18(4):47-50, 76. PubMed ID: 11649513
    [No Abstract]   [Full Text] [Related]  

  • 15. Ethical oxymora for risk assessment practitioners.
    Greenberg MR; Spiro H; McIntyre R
    Account Res; 1991; 1(4):245-57. PubMed ID: 11651458
    [No Abstract]   [Full Text] [Related]  

  • 16. Fraud squad moves in on universities.
    Cross M; Connor S; Anderson I
    New Sci; 1985 Jun; 106(1459):8. PubMed ID: 11655696
    [No Abstract]   [Full Text] [Related]  

  • 17. University-industry relationships in genetic research: potential opportunities and pitfalls.
    Walsh ME; Graber GC; Wolfe AK
    Account Res; 1997; 5(4):265-82. PubMed ID: 11656993
    [No Abstract]   [Full Text] [Related]  

  • 18. Secrets of the artificial heart business.
    Anderson I
    New Sci; 1984 Dec; 104(1433):7. PubMed ID: 11655657
    [No Abstract]   [Full Text] [Related]  

  • 19. The search for a cure: combating the problem of conflicts of interest that currently plagues biomedical research.
    Clamon JB
    Iowa Law Rev; 2003 Oct; 89(1):235-71. PubMed ID: 15732180
    [No Abstract]   [Full Text] [Related]  

  • 20. Conflict-of-interest debate stirs mixed reaction at NIH.
    Macilwain C
    Nature; 1994 Feb; 367(6462):401. PubMed ID: 8107786
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 18.